High Quantitative CRP And Low Albumin as Marker of Disease Activity in Patients with Rheumatoid Arthritis
DOI:
https://doi.org/10.61919/jhrr.v4i2.980Keywords:
C-Reactive Protein, Disease Activity, Rheumatoid Arthritis, Serum AlbuminAbstract
Background: Rheumatoid arthritis (RA) is a chronic inflammatory disorder characterized by synovial tissue inflammation, leading to joint damage, pain, and systemic effects.
Objective: To evaluate the utility of high quantitative C-reactive protein (CRP) and low serum albumin levels as markers of disease activity in RA patients.
Methods: This cross-sectional study was conducted at the Department of Rheumatology, Khyber Teaching Hospital, Peshawar, from September 1, 2023, to February 29, 2024. Male and female RA patients aged 18 to 70 years were enrolled. Disease activity was assessed using the Disease Activity Score 28 (DAS 28). Serum CRP and albumin levels were measured and compared with DAS28 scores.
Results: A total of 105 patients were included, with a majority being female (n=60, 57.1%). The mean age was 52.4 ± 9.8 years, with most participants aged between 40 and 50 years (n = 35, 33.3%). Elevated CRP levels were associated with increased disease activity, with an odds ratio of 1.82 (95% CI: 1.53 - 2.17, p < 0.001). Conversely, lower albumin levels were linked to higher disease activity, with an odds ratio of 3.47 (95% CI: 4.35 - 2.63, p < 0.001).
Conclusion: Serum CRP and albumin levels serve as valuable indicators for assessing disease activity in RA patients, highlighting their potential role in clinical management.
Downloads
References
Shrivastava AK, Pandey A. Inflammation and rheumatoid arthritis. Journal of physiology and biochemistry. 2013 Jun;69:335-47.
Wu D, Luo Y, Li T, Zhao X, Lv T, Fang G, Ou P, Li H, Luo X, Huang A, Pang Y. Systemic complications of rheumatoid arthritis: Focus on pathogenesis and treatment. Frontiers in Immunology. 2022 Dec 22;13:1051082.
Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, Liang MH, Kremers HM, Mayes MD, Merkel PA, Pillemer SR. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I. Arthritis & Rheumatism. 2008 Jan;58(1):15-25.
Alamanos Y, Drosos AA. Epidemiology of adult rheumatoid arthritis. Autoimmunity reviews. 2005 Mar 1;4(3):130-6.
Boissier MC, Biton J, Semerano L, Decker P, Bessis N. Origins of rheumatoid arthritis. Joint Bone Spine. 2020 Jul 1;87(4):301-6.
Aletaha D, Smolen JS. Diagnosis and management of rheumatoid arthritis: a review. Jama. 2018 Oct 2;320(13):1360-72.
Smolen JS, Aletaha D. Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges. Nature Reviews Rheumatology. 2015 May;11(5):276-89.
Salaffi F, Di Carlo M, Farah S, Marotto D, Atzeni F, Sarzi-Puttini P. Rheumatoid Arthritis disease activity assessment in routine care: performance of the most widely used composite disease activity indices and patient-reported outcome measures. Acta Bio Medica: Atenei Parmensis. 2021;92(4).
Salaffi F, Di Carlo M, Carotti M, Sarzi-Puttini P. The subjective components of the Disease Activity Score 28-joints (DAS28) in rheumatoid arthritis patients and coexisting fibromyalgia. Rheumatology international. 2018 Oct;38(10):1911-8.
Mackay A, Erskine J, Kerr O, Marshall L, Davidson A. C-Reactive protein and albumin as prognostic markers in intensive care. Critical Care. 2010 Mar 1;14(Suppl 1):P430.
Ansar W, Ghosh S, Ansar W, Ghosh S. Inflammation and inflammatory diseases, markers, and mediators: Role of CRP in some inflammatory diseases. Biology of C reactive protein in health and disease. 2016:67-107.
Pope JE, Choy EH. C-reactive protein and implications in rheumatoid arthritis and associated comorbidities. InSeminars in arthritis and rheumatism 2021 Feb 1 (Vol. 51, No. 1, pp. 219-229). WB Saunders.
Gremese E, Bruno D, Varriano V, Perniola S, Petricca L, Ferraccioli G. Serum Albumin Levels: A Biomarker to Be Repurposed in Different Disease Settings in Clinical Practice. Journal of Clinical Medicine. 2023 Sep 17;12(18):6017.
Goldwasser P, Feldman J. Association of serum albumin and mortality risk. Journal of clinical epidemiology. 1997 Jun 1;50(6):693-703.
Machold KP, Stamm TA, Nell VP, Pflugbeil S, Aletaha D, Steiner G, et al.. Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease. Rheumatology. 2007 Feb 1;46(2):342-9.
Kovacs M, Obrosky S, George C. The course of major depressive disorder from childhood to young adulthood: Recovery and recurrence in a longitudinal observational study. Journal of affective disorders. 2016 Oct 1;203:374-81.
Mease PJ, Stryker S, Liu M, Salim B, Rebello S, Gharaibeh M, et al. Treatment patterns in rheumatoid arthritis patients newly initiated on biologic and conventional synthetic disease-modifying antirheumatic drug therapy and enrolled in a North American clinical registry. Arthritis research & therapy. 2021 Dec;23:1-3.
Tamhane A. Measuring disease activity and use of complementary and alternative medicine in African-Americans with Rheumatoid Arthritis. The University of Alabama at Birmingham; 2012.
Keshteli AH, Valcheva R, Nickurak C, Park H, Mandal R, van Diepen K. et al,. Anti-inflammatory diet prevents subclinical colonic inflammation and alters metabolomic profile of ulcerative colitis patients in clinical remission. Nutrients. 2022 Aug 11;14(16):3294.
Batur EB, LEVENDOĞLU F. Is Serum C-Reactive Protein to Albumin Ratio Be A New Biomarker for Assessing Disease Activity and Quality of Life in Rheumatoid Arthritis?. Osmangazi Tıp Dergisi. 2021;44(3):301-8.
Ajeganova S, Andersson ML, Frostegård J, Hafström I. Disease factors in early rheumatoid arthritis are associated with differential risks for cardiovascular events and mortality depending on age at onset: a 10-year observational cohort study. The Journal of rheumatology. 2013 Dec 1;40(12):1958-66.
Kalia M. Biomarkers for personalized oncology: recent advances and future challenges. Metabolism. 2015 Mar 1;64(3):S16-21.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Najeeb Ullah, Amjad Ali, Muhammad Ayub
This work is licensed under a Creative Commons Attribution 4.0 International License.
